Reckitt Benckiser Group plc
RKT.LConsumer DefensiveLSEHousehold & Personal Products
Scan Results
Daily timeframePart of the consumer defensive sector, Reckitt Benckiser Group plc (RKT.L) is listed under Household & Personal Products. The company carries a $29.85B market cap, placing it firmly in the large-cap category. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names.
Market Cap
$29.85B
Beta
0.25
P/E (TTM)
9.58
P/E (Fwd)
13.00
EPS (TTM)
$4.89
EPS (Fwd)
$3.60
ROE
44.2%
ROA
8.5%
Cash
$1.95B
Total Debt
$8.53B
Free CF
$3.00B
52W Change
-8.8%
Annual Financials
Cash vs Debt
On the balance sheet, RKT.L has $1.95B in cash with $8.53B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $3.00B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 44.2%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $14.45B (2022) to $14.21B (2025).
RKT.L's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Reckitt Benckiser Group plc and its sector.